unresectable, locally advanced HER2-positive Adenocarcinomas of the Gastroesophageal Junction
unresectable, locally advanced HER2-positive Adenocarcinomas of the Gastroesophageal Junction is the indication for 1 drug in DrugBank. It is covered by 3 curated, structured indications.
- Indicated drugs
What you can answer from here — as of October 23, 2026
1Indicated drugWith each drug's targets and mechanismListed above
3Structured indicationsPopulation, line of therapy, route and combination as fields, not proseSign in
Which approved drugs for unresectable, locally advanced HER2-positive Adenocarcinomas of the Gastroesophageal Junction share a target, and which companies have late-stage candidates against it?
Create a free account or log in to explore the full data card.
Create Account